Trane Launches "Cool Air, Hot Takes" Podcast for HVAC Professionals
DAVIDSON, NC / / March 27, 2025 / Trane® - by Trane Technologies (NYSE: TT), a global climate innovator, has launched "Cool Air, Hot Takes," a new podcast designed to equip Heating, Ventilation and Air Conditioning (HVAC) professionals with the knowledge and insights they need to thrive in a rapidly evolving industry. Produced by Trane, the podcast explores the latest trends, innovations, and challenges shaping the future of building climate control.
As buildings increasingly prioritize energy efficiency, indoor environmental quality, and occupant well-being, the role of HVAC has never been more critical. The "Cool Air, Hot Takes" podcast will provide a valuable platform through which HVAC professionals can stay informed about these evolving trends, connect with industry leaders, and gain practical knowledge to implement sustainable solutions in their projects.
Hosted by HVAC industry veterans Charlie Jelen and Dan Gentry who combined have more than 30 years of industry experience, "Cool Air, Hot Takes" delivers a unique blend of in-depth industry insights, unfiltered opinions, and expert interviews, all with a touch of humor. Listeners can expect to hear discussions on topics ranging from sustainable HVAC solutions and the integration of smart building technologies to the growing demand for improved indoor air quality and best practices for installation and maintenance.
"Navigating the rapidly evolving HVAC landscape can be challenging," explains Charlie Jelen, co-host of "Cool Air, Hot Takes" and Sustainable Systems Sales Leader, Trane Technologies. "Dan and I are bringing our passion for the industry and a bit of humor to the table, making it easier and more enjoyable for professionals to stay informed and engaged."
The first episode, titled "How Venture Capital is Shaping the Future of HVAC," features an interview with Jon Horne of the Idea Fund, which was established to invest in seed and early-stage startup companies. The episode explores how venture capital is shaping the HVAC industry and why now is one of the most disruptive times the industry has seen in decades.
Listen to "Cool Air, Hot Takes" on Apple Podcasts, Spotify, Amazon Music, Pocket Casts and on our website. New episodes will be released bi-weekly.About TraneTrane - by Trane Technologies (NYSE:TT), a global climate innovator - creates comfortable, energy efficient indoor environments through a broad portfolio of heating, ventilating and air conditioning systems and controls, services, parts and supply. For more information, please visit www.trane.com or www.tranetechnologies.com.
All trademarks referenced are the trademarks of their respective owners.© 2025 Trane. All Rights Reserved.
Trane's new "Cool Air, Hot Takes" podcast is designed to equip HVAC professionals with the knowledge and insights they need to thrive in a rapidly evolving industry. The podcast explores the latest trends, innovations, and challenges shaping the future of building climate control.
View additional multimedia and more ESG storytelling from Trane Technologies on 3blmedia.com.
Contact Info:Spokesperson: Trane TechnologiesWebsite: https://www.3blmedia.com/profiles/trane-technologiesEmail: info@3blmedia.com
SOURCE: Trane Technologies
View the original press release on ACCESS Newswire
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Viking Therapeutics stock falls 37% on high dropout rate in obesity trial
-- Viking Therapeutics (NASDAQ:VKTX) stock plunged as much as 37% Tuesday after revealing results from its Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment, while Eli Lilly (NYSE:LLY) shares gained 1.5% as analysts pointed to competitive advantages. The trial demonstrated that Viking's oral tablet formulation of VK2735, a dual GLP-1 and GIP receptor agonist, met its primary endpoint with patients losing up to 12.2% of body weight after 13 weeks compared to 1.3% for placebo. Despite the weight loss efficacy, the 28% treatment discontinuation rate among patients receiving VK2735 versus 18% for placebo raised significant concerns among investors and analysts. Mizuho analyst Jared Holz highlighted competitive disadvantages compared to Eli Lilly's offerings: "Data look inferior to LLY on almost all metrics and the thing to consider here is that patients discontinued at such a high rate over 13-weeks vs. LLY in the mid 20% range --- but over 72-weeks; A much longer trial, and therefor LLY looks far better head-to-head. This probably shutters hope for VKTX a bigtime player in the oral obesity market over the near to medium term." JPMorgan (NYSE:JPM) analyst Hardik Parikh offered a more balanced view, noting, "In 13 weeks, the three highest-dosing arms of 60/90/120mg showed avg pbo-adj weight loss of ~7.5%, 10%, 11%, which we think is very strong compared with other orals in development. Tolerability overall was manageable, but it was worse than we expected based on the ph1 performance." Parikh added that while the adverse event profile wasn't as clean as in Phase 1 trials, "we still think oral vk-2735 offers strong efficacy with a manageable tolerability profile." Viking reported that 99% of gastrointestinal-related adverse events were mild or moderate. The company also highlighted an exploratory maintenance dosing arm showing weight loss could be maintained at lower doses. The major adverse events included vomiting rates of 20-35% in the three highest dose arms compared to about 10% for placebo, and nausea rates of approximately 58% for patients on treatment versus 48% for placebo. Related articles Viking Therapeutics stock falls 37% on high dropout rate in obesity trial Tesla robotaxi trial impresses, pricing power clear: William Blair Palo Alto Networks gains after strong earnings and Bank of America upgrade
Yahoo
an hour ago
- Yahoo
2 Growth Stocks to Buy With $200 and Hold Forever
Key Points Unity is in the middle of a turnaround, and growth is just around the corner. AMD is winning market share and building a massive artificial intelligence (AI) chip business. Both growth stocks are under $200 per share. 10 stocks we like better than Unity Software › You don't need much money at all to invest in some of the best growth stocks available. If you've got $200 and are ready to put it to work in the stock market, Unity Software (NYSE: U) and Advanced Micro Devices (NASDAQ: AMD) look like solid bets. Unity is on the cusp of a return to growth, and AMD is stealing market share from its biggest rival. 1. Unity Software: Staging a comeback Video game engine developer Unity has reached an inflection point, according to CEO Matthew Bromberg. The company's accelerated pace of development, its work to regain trust after the Runtime Fee debacle, and its artificial intelligence (AI)-powered Vector ad platform have brought the company close to a return to growth. Overall revenue was still down slightly in the second quarter, but things are moving in the right direction. Unity's Create Solutions segment, which includes its game engine, grew revenue in the second quarter, thanks to a large customer win and an increase in subscription revenue. The Grow Solutions segment, which focuses on advertising, shrank slightly. However, Unity Ad Network grew revenue by 15% compared to the first quarter, thanks to the new Vector platform, which was offset by weakness in other areas. In the third quarter, Unity expects its Grow Solutions segment to report mid-single-digit revenue growth compared to the second quarter, a sign the Vector platform is gaining traction. Create Solutions will be weaker due to the large customer win in the second quarter that won't be repeated. Overall revenue is expected between $440 million and $450 million, up from the second quarter at the midpoint. Unity may not look like much of a growth stock right now, but the company has all the pieces in place to become a long-term winner. The Unity game engine is widely used across the video game industry, and switching costs are significant. On the advertising side, the Vector platform aims to fix issues that have plagued that part of the business for years. As Unity gets back on its feet, now's a great time to buy stock. 2. AMD: A force in CPUs and AI AMD still finds itself in a second-place position behind Intel in the PC and server CPU markets, but the company has gained an incredible amount of ground thanks to good products and Intel's various issues. AMD managed a 27.3% unit share and a 41% revenue share in the server CPU market during the second quarter of 2025. Eight years ago, Intel had a near-monopoly. A similar story has played out in the PC CPU market. AMD managed a 32.2% unit share of the desktop CPU market and a 20.6% unit share of the notebook CPU market, both of which are up dramatically over the past decade. The company's Ryzen CPUs have been winning over consumers as Intel struggled with stability issues for its Raptor Lake chips and later a lackluster launch for Arrow Lake. Outside of CPUs, AMD has built a solid AI accelerator business as well. The company is still far behind market leader Nvidia, but its Instinct data center GPUs are now a multibillion-dollar annual revenue business. The company sees this as a long-term opportunity as AI chip demand continues to explode, with the potential for tens of billions of dollars in annual revenue down the road. AMD faces a few risks. First, Intel under its new CEO could become more aggressive and put pressure on AMD's CPU businesses. Second, if the AI boom starts to fizzle out, the AI accelerator business may not be as lucrative in the long run as the company is assuming. However, even with those risks, AMD is a much stronger company than it was even five years ago, and it should continue to thrive in the years ahead. Do the experts think Unity Software is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Unity Software make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,070% vs. just 184% for the S&P — that is beating the market by 885.55%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Timothy Green has positions in Intel. The Motley Fool has positions in and recommends Advanced Micro Devices, Intel, Nvidia, and Unity Software. The Motley Fool recommends the following options: short August 2025 $24 calls on Intel. The Motley Fool has a disclosure policy. 2 Growth Stocks to Buy With $200 and Hold Forever was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Announces Details of Liquidation
NEW YORK--(BUSINESS WIRE)-- BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (Ticker: XALCX) (the "Fund") announced today additional details concerning the liquidation and termination of the Fund. In accordance with the Fund's Charter, the Fund's Board of Directors has approved the termination date of the Fund. The Fund will terminate at the close of business on or about August 29, 2025, approximately the sixth anniversary of the closing date of the Fund's initial public offering (the "Termination Date"). The final NAV is expected to be calculated on the Termination Date with final distributions to be made the week of September 2, 2025. Important Information BNY Mellon Investment Adviser, Inc., the investment adviser for the Fund, is part of BNY Investments. BNY Investments is one of the world's largest asset managers, with $2.1 trillion in assets under management as of June 30, 2025. Through a client-first approach, BNY Investments brings investors specialist expertise through its seven investment firms offering solutions across every major asset class and backed by the breadth and scale of BNY. Additional information on BNY Investments is available on Follow us on LinkedIn for the latest company news and activity. BNY Investments is a division of BNY, which has $55.8 trillion in assets under custody and/or administration as of June 30, 2025. Established in 1784, BNY is America's oldest bank. Today, BNY powers capital markets around the world through comprehensive solutions that help clients manage and service their financial assets throughout the investment life cycle. BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Additional information is available on Follow us on LinkedIn or visit our newsroom for the latest company news. BNY Investments' website is intended to allow investors public access to information regarding the Fund and does not, and is not intended to, incorporate the website in this release.
